IBDEI0DA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6341,1,5,0)
 ;;=5^733.01
 ;;^UTILITY(U,$J,358.3,6341,2)
 ;;=^87188
 ;;^UTILITY(U,$J,358.3,6342,0)
 ;;=733.02^^44^510^11
 ;;^UTILITY(U,$J,358.3,6342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6342,1,4,0)
 ;;=4^OSTEOPOROSIS,IDIOPATHIC
 ;;^UTILITY(U,$J,358.3,6342,1,5,0)
 ;;=5^733.02
 ;;^UTILITY(U,$J,358.3,6342,2)
 ;;=^272692
 ;;^UTILITY(U,$J,358.3,6343,0)
 ;;=733.03^^44^510^9
 ;;^UTILITY(U,$J,358.3,6343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6343,1,4,0)
 ;;=4^OSTEOPOROSIS,DISUSE
 ;;^UTILITY(U,$J,358.3,6343,1,5,0)
 ;;=5^733.03
 ;;^UTILITY(U,$J,358.3,6343,2)
 ;;=^265526
 ;;^UTILITY(U,$J,358.3,6344,0)
 ;;=733.09^^44^510^10
 ;;^UTILITY(U,$J,358.3,6344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6344,1,4,0)
 ;;=4^OSTEOPOROSIS,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,6344,1,5,0)
 ;;=5^733.09
 ;;^UTILITY(U,$J,358.3,6344,2)
 ;;=^87762
 ;;^UTILITY(U,$J,358.3,6345,0)
 ;;=268.2^^44^510^6
 ;;^UTILITY(U,$J,358.3,6345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6345,1,4,0)
 ;;=4^OSTEOMALACIA NOS
 ;;^UTILITY(U,$J,358.3,6345,1,5,0)
 ;;=5^268.2
 ;;^UTILITY(U,$J,358.3,6345,2)
 ;;=^87103
 ;;^UTILITY(U,$J,358.3,6346,0)
 ;;=756.52^^44^510^7
 ;;^UTILITY(U,$J,358.3,6346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6346,1,4,0)
 ;;=4^OSTEOPETROSIS
 ;;^UTILITY(U,$J,358.3,6346,1,5,0)
 ;;=5^756.52
 ;;^UTILITY(U,$J,358.3,6346,2)
 ;;=^87143
 ;;^UTILITY(U,$J,358.3,6347,0)
 ;;=579.9^^44^510^1
 ;;^UTILITY(U,$J,358.3,6347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6347,1,4,0)
 ;;=4^MALABSORPTION SYNDROME
 ;;^UTILITY(U,$J,358.3,6347,1,5,0)
 ;;=5^579.9
 ;;^UTILITY(U,$J,358.3,6347,2)
 ;;=^123941
 ;;^UTILITY(U,$J,358.3,6348,0)
 ;;=275.40^^44^510^2
 ;;^UTILITY(U,$J,358.3,6348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6348,1,4,0)
 ;;=4^METABOLISM D/O,CALCIUM
 ;;^UTILITY(U,$J,358.3,6348,1,5,0)
 ;;=5^275.40
 ;;^UTILITY(U,$J,358.3,6348,2)
 ;;=^18161
 ;;^UTILITY(U,$J,358.3,6349,0)
 ;;=275.2^^44^510^3
 ;;^UTILITY(U,$J,358.3,6349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6349,1,4,0)
 ;;=4^METABOLISM D/O,MAGNESIUM
 ;;^UTILITY(U,$J,358.3,6349,1,5,0)
 ;;=5^275.2
 ;;^UTILITY(U,$J,358.3,6349,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,6350,0)
 ;;=275.3^^44^510^5
 ;;^UTILITY(U,$J,358.3,6350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6350,1,4,0)
 ;;=4^METABOLISM D/O,PHOSPHORUS
 ;;^UTILITY(U,$J,358.3,6350,1,5,0)
 ;;=5^275.3
 ;;^UTILITY(U,$J,358.3,6350,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,6351,0)
 ;;=275.9^^44^510^4
 ;;^UTILITY(U,$J,358.3,6351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6351,1,4,0)
 ;;=4^METABOLISM D/O,MINERAL
 ;;^UTILITY(U,$J,358.3,6351,1,5,0)
 ;;=5^275.9
 ;;^UTILITY(U,$J,358.3,6351,2)
 ;;=^267943
 ;;^UTILITY(U,$J,358.3,6352,0)
 ;;=588.0^^44^510^13
 ;;^UTILITY(U,$J,358.3,6352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6352,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,6352,1,5,0)
 ;;=5^588.0
 ;;^UTILITY(U,$J,358.3,6352,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,6353,0)
 ;;=268.9^^44^510^14
 ;;^UTILITY(U,$J,358.3,6353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6353,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,6353,1,5,0)
 ;;=5^268.9
 ;;^UTILITY(U,$J,358.3,6353,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,6354,0)
 ;;=251.2^^44^511^15
 ;;^UTILITY(U,$J,358.3,6354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6354,1,4,0)
 ;;=4^HYPOGLYCEMIA NOS
 ;;^UTILITY(U,$J,358.3,6354,1,5,0)
 ;;=5^251.2
 ;;^UTILITY(U,$J,358.3,6354,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,6355,0)
 ;;=250.01^^44^511^7
 ;;^UTILITY(U,$J,358.3,6355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6355,1,4,0)
 ;;=4^DMI w/o COMPLICATIONS
